Development of ZMYM2‐FGFR1 driven AML in human CD34+ cells in immunocompromised mice
暂无分享,去创建一个
[1] M. Bessho,et al. A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation , 2014, Blood Cancer Journal.
[2] T. George,et al. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review , 2013, International journal of laboratory hematology.
[3] E. Kitamura,et al. Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models. , 2013, Blood.
[4] T. George,et al. Myeloid and lymphoid Neoplasms with FGFR1 abnormalities: diagnostic and therapeutic challenges , 2013, American journal of hematology.
[5] J. Cowell,et al. Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities , 2012, Leukemia.
[6] J. Cowell,et al. Acute Progression of BCR-FGFR1 Induced Murine B-Lympho/Myeloproliferative Disorder Suggests Involvement of Lineages at the Pro-B Cell Stage , 2012, PloS one.
[7] J. Cowell,et al. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases. , 2011, Cancer research.
[8] D. Gisselsson,et al. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice. , 2010, Blood.
[9] L. Medeiros,et al. 8p11 myeloproliferative syndrome: a review. , 2010, Human pathology.
[10] Xiurong Li,et al. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase. , 2009, Blood.
[11] D. Fabbro,et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. V. van Etten,et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. , 2004, Cancer cell.
[13] J. Cowell,et al. The Oncogenic Fusion Protein-tyrosine Kinase ZNF198/Fibroblast Growth Factor Receptor-1 Has Signaling Function Comparable with Interleukin-6 Cytokine Receptors* , 2003, The Journal of Biological Chemistry.
[14] D. Birnbaum,et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). , 2000, Blood.
[15] J. Cowell,et al. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. , 1998, Blood.
[16] E. Jaffe,et al. T‐Cell Lymphoblastic Lymphoma With Eosinophilia Associated With Subsequent Myeloid Malignancy , 1992, The American journal of surgical pathology.